Literature DB >> 8482099

Lung lavage with oxygenated perfluorochemical liquid in acute lung injury.

P S Richman1, M R Wolfson, T H Shaffer.   

Abstract

OBJECTIVE: To investigate the effects of lung lavage with oxygenated liquid perfluorochemical on gas exchange, lung mechanics, and cardiac function in animals with acute lung injury.
DESIGN: Prospective, randomized, controlled trial.
SETTING: Animal laboratory.
SUBJECTS: Eight adult cats (2 to 4 kg, random sex).
INTERVENTIONS: Two insults were combined to cause lung injury: oleic acid infusion and saline whole-lung wash. Animals were assigned to either the control or treatment group which consisted of a perfluorochemical liquid (Rimar 101) lavage. Perfluorochemical liquid lavage was performed three times at hourly intervals after lung injury. Three other cats with identical injury but no perfluorochemical liquid lavage served as control animals. All cats were ventilated with an FIO2 of 0.95 and positive end-expiratory pressure of 2 cm H2O continuously.
MEASUREMENTS AND MAIN RESULTS: Arterial blood gas tensions and pH, dynamic pulmonary compliance were measured at 15-min intervals. Cardiac index was assessed hourly, and lung fluid was collected after each of the three perfluorochemical liquid lavages. Arterial oxygen tension and pulmonary compliance deteriorated abruptly after lung injury in all cats, and improved significantly (p < .001, two-way analysis of variance) 15 mins after perfluorochemical liquid lavage. These parameters gradually returned to their baseline over 60 mins. Arterial blood pressure and cardiac index decreased after injury in all cats, and were not significantly changed after perfluorochemical liquid lavage. Hemorrhagic fluid was recovered from distal airways by perfluorochemical liquid lavage, despite prior suctioning of the airway.
CONCLUSIONS: Perfluorochemical liquid lavage removes pulmonary edema fluid and improves gas exchange and the mechanical properties of the lung, after acute severe lung injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482099     DOI: 10.1097/00003246-199305000-00022

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  [Experimental study in partial liquid ventilation for acute respiratory failure after ischemia reperfusion pulmonary injury in a rabbit model].

Authors:  Y Momoki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-01

Review 2.  Administration of Drugs/Gene Products to the Respiratory System: A Historical Perspective of the Use of Inert Liquids.

Authors:  Deepthi Alapati; Thomas H Shaffer
Journal:  Front Physiol       Date:  2022-05-10       Impact factor: 4.755

3.  Partial liquid ventilation in adult patients with ARDS: a multicenter phase I-II trial. Adult PLV Study Group.

Authors:  R B Hirschl; S Conrad; R Kaiser; J B Zwischenberger; R H Bartlett; F Booth; V Cardenas
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

Review 4.  Liquid ventilation: an alternative ventilation strategy for management of neonatal respiratory distress.

Authors:  T H Shaffer; M R Wolfson
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

5.  Liquid ventilation improves pulmonary function, gas exchange, and lung injury in a model of respiratory failure.

Authors:  R B Hirschl; A Parent; R Tooley; M McCracken; K Johnson; T H Shaffer; M R Wolfson; R H Bartlett
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

6.  Infectious and inflammatory dissemination are affected by ventilation strategy in rats with unilateral pneumonia.

Authors:  Frédérique Schortgen; Lila Bouadma; Marie-Laure Joly-Guillou; Jean-Damien Ricard; Didier Dreyfuss; Georges Saumon
Journal:  Intensive Care Med       Date:  2004-01-22       Impact factor: 17.440

7.  Evaluation of lung recovery after static administration of three different perfluorocarbons in pigs.

Authors:  Mourad Chenoune; Ludovic De Rochefort; Patrick Bruneval; Fanny Lidouren; Matthias Kohlhauer; Aurélien Seemann; Bijan Ghaleh; Matthias Korn; Rose-Marie Dubuisson; Anis Ben Yahmed; Xavier Maître; Daniel Isabey; Jean-Damien Ricard; Richard E Kerber; Luc Darrasse; Alain Berdeaux; Renaud Tissier
Journal:  BMC Pharmacol Toxicol       Date:  2014-09-25       Impact factor: 2.483

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.